for a number of reasons, such as keeping FT Sites reliable and secure,
personalising content and ads, providing social media features and to
analyse how our Sites are used.
A new world is possible.
Let's not go back to what wasn't working anyway.
Add this topic to your myFT Digest for news straight to your inbox
Plan to spin off consumer division has failed to thrill investors
Mandate demanding staff are vaccinated or tested seen as unworkable by some employers
Political will is needed to address absence of sufficient financial incentives for new drugs
Failure to ensure they reach world’s poorest increases health risks, says pharma body
Zoologists fear wildlife may become reservoir of infection that could be transmitted to people
The pandemic has forced a reassessment of which health systems serve citizens best
The coronavirus pandemic has overturned assumptions about the way the world’s health systems work. This report looks at how they are rising to the challenges they face, from Covid messaging in polyglot South Africa to joined-up care in fast-ageing Japan
Poverty, corruption and multiple languages are all barriers to clear communication on health
Relatively humble innovations can pave the way for cutting-edge advances
The country has plenty of hospitals but remains a digital laggard
Outreach project aims to win trust from migrant groups and curb spread of hepatitis B
An inside look at how pandemic-hit hospitals learned to work in new ways
Vote by European Medicines Agency panel deals setback to controversial $56,000-a-year treatment
US government funding for scientific research that splices deadly viruses to make them more transmissible is under scrutiny amid safety concerns
Company applies for regulatory greenlight after reaching deal to expand access to medication in developing countries
Smart rings and watches are shifting from activity trackers to sophisticated healthcare tools
Executives fear workers may be lured away by retailers such as Amazon just as winter pressure on health service mounts
Pharma group partnership with Oxford university hits 2bn-dose milestone
Children aged 16 and 17 will also be eligible for second dose to increase protection against infection
Analysing the genes of those who appear to be naturally resistant could lead to antiviral treatments
BD chief says pandemic is coming ‘under control’ but prices will not return to previous levels
New medicines from Pfizer and Merck could take some pressure off hospitals. But will they work on the already vaccinated?
A successful split of the consumer and pharma divisions would, on paper, unlock value
UK prime minister warns of ‘storm clouds’ gathering over continental Europe as infection rates soar in some nations
Concerns raised over Robert Califf’s previous stint at the US drugs regulator and its approach to the opioid epidemic